Bastien M, Poirier P, Lemieux I, Després JP (2014) Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56(4):369–381. https://doi.org/10.1016/j.pcad.2013.10.016
Barquera S, Hernández-Barrera L, Trejo-Valdivia B, Shamah T, Campos-Nonato I, Rivera-Dommarco J (2020) Obesity in Mexico, prevalence and trends in adults Ensanut 2018–19]. Salud Publica Mex 62(6):682–692. https://doi.org/10.21149/11630
Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA (2019) Diet, gut microbiota, and obesity: links with host genetic and epigenetics and potential applications. Adv Nutr. https://doi.org/10.1093/advances/nmy078
Article PubMed PubMed Central Google Scholar
Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH et al (2020) Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol 11:571731. https://doi.org/10.3389/fimmu.2020.571231
Article CAS PubMed PubMed Central Google Scholar
Guo S, Al-Sadi R, Said HM, Ma TY (2013) Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro an in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182(2):375–387. https://doi.org/10.1016/j.ajpath.2012.10.014
Article CAS PubMed PubMed Central Google Scholar
Saad MJ, Santos A, Prada PO (2016) Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology 31(4):283–293. https://doi.org/10.1152/physiol.00041.2015
Article CAS PubMed Google Scholar
Cani PD, Bibilono R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470–1481. https://doi.org/10.2337/db07-1403
Article CAS PubMed Google Scholar
Radilla-Vázquez RB, Parra-Rojas I, Martínez-Hernández NE, Márquez-Sandoval YF, Illades-Aguiar B, Castro-Alarcón N (2016) Gut microbiota and metabolic endotoxemia in young obese Mexican subjects. Obes Facts 9(1):1–11. https://doi.org/10.1159/000442479
Article CAS PubMed PubMed Central Google Scholar
Tam J, Coller JK, Hughes PA, Prestidge CA, Bowen JM (2021) Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol 40(1):5–21. https://doi.org/10.1007/s12664-020-01114-y
Article PubMed PubMed Central Google Scholar
Kim JJ, Sears DD (2010) TLR4 and Insulin Resistance. Gastroenterol Res Pract 2010:212563. https://doi.org/10.1155/2010/212563
Article PubMed PubMed Central Google Scholar
Ragnarsdóttir B, Jönsson K, Urbano A, Grönberg-Hernandez J, Lutay N, Tammi M et al (2010) Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS ONE 5(5):e10734. https://doi.org/10.1371/journal.pone.0010734
Article CAS PubMed PubMed Central Google Scholar
Ziakas PD, Prodromou ML, El Khoury J, Zintzaras E, Mylonakis E (2013) The role of TLR4 896 A>G and 1196 C>T in susceptibility to infections: a review and meta-analysis of genetic association studies. PLoS ONE 8(11):e81047. https://doi.org/10.1371/journal.pone.0081047
Article CAS PubMed PubMed Central Google Scholar
Franchimont D, Vermeire S, Housni EI, H, Pierik M, Van Steen K, Gustot T, et al (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn´s disease and ulcerative colitis. Gut 53(7):987–992. https://doi.org/10.1136/gut.2003.030205
Article CAS PubMed PubMed Central Google Scholar
Figueroa L, Xiong Y, Song C, Piao W, Vogel SN, Medvedev AE (2013) The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Inmmunol 188(9):4506–4515. https://doi.org/10.4049/jimmunol.1200202
Steinhardt AP, Aranguren F, Tellechea ML, Gómez Rosso LA, Brites FD, Martínez-Larrad MT et al (2010) A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Metabolism 59(5):711–717. https://doi.org/10.1016/j.metabol.2009.09.015
Article CAS PubMed Google Scholar
Ao R, Wang Y, Zhnag DR, Du YQ (2015) Role of TLR4 rs4986790A>G and rs4986791C>T polymorphisms in the risk of inflammatory bowel disease. Gastroenterol Res Pract 2015:141070. https://doi.org/10.1155/2015/141070
Article PubMed PubMed Central Google Scholar
Cuda C, Badawi A, Karmali M, EI-Sohemy A. (2011) Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 60(8):1131–1135. https://doi.org/10.1016/j.metabol.2010.12.006
Article CAS PubMed Google Scholar
Belforte FS, Leskow FC, Posku E, Steinhardt AP (2013) Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis. Mol Biol Rep 40(4):3015–3020. https://doi.org/10.1007/s11033-012-2374-5
Article CAS PubMed Google Scholar
Balistreri CR, Bonfigli AR, Boemi M, Olivieri F, Ceriello A, Genovese S et al (2014) Evidences of +896 A/G TLR4 polymorphism as an indicative of prevalence of complications in T2DM patients. Mediators Inflamm 2014:973139. https://doi.org/10.1155/973139
Article PubMed PubMed Central Google Scholar
Fan J, Liang R (2020) Quantitative assessment of TLR4 gene polymorphisms and T2DM risk: a meta-analysis. Mol Genet Genomic Med 8(10):e1466. https://doi.org/10.1002/mgg3.1466
Article CAS PubMed PubMed Central Google Scholar
Han K, Li YP (2018) Prognostic predictive value of TLR4 polymorphisms in Han Chinese population with hypertrophic cardiomyopathy. Kaohsiung J Med Sci 34(10):569–575. https://doi.org/10.1016/j.kjms.2018.05.004
Semlali A, Al Mutairi M, AOqlaAlanazi I, AwadAlhohi H, Reddy Parine N, AlJafari AA, et al (2019) Toll-like receptor 4 polymorphisms in Saudi population with cardiovascular disease. Mol Genet Genomic Med. https://doi.org/10.1002/mgg3.852
Article PubMed PubMed Central Google Scholar
Castro-Alarcón N, Rodríguez-García R, Ruíz-Rosas M, Muñoz-Valle JF, Guzmán-Guzmán IP, Parra-Rojas I et al (2018) Association between TLR4 polymorphisms (896 A>G, 1196 C>T, -2570 A>G, -2081 G>A) and virulence factors in uropathogenic Escherichia coli. Clin Exp Med 19(1):105–113. https://doi.org/10.1007/s10238-018-0527-0
Zhou Q, Wang C, Wang X, Wu X, Zhu Z, Liu B et al (2014) Association between TLR4 (+896A/G and +1196C/T) polymorphisms and gastric cancer risk: an update meta-analysis. PLoS ONE 9(10):e109605. https://doi.org/10.1371/journal.pone.0109605
Article CAS PubMed PubMed Central Google Scholar
Sharif E, Al-Wakeel M, Mohamed A, Kerkadi A, Rizk N (2020) TLR4 Receptor D299G/T399I haplotype polymorphism is associated with insulin resistance in obese female subjects. Genes (Basel) 11(7):814. https://doi.org/10.3390/genes11070814
Article CAS PubMed Google Scholar
World Health Organization. Physical status: the use and interpretation of anthropometria. Report of a WHO Expert Committee. Geneva, World Health Organization, (Technical Report Series, No. 854) 329, 1995.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung and blood institute scientific statement: executive summary. Crit Pathw Cardiol 4(4):198–203. https://doi.org/10.1097/00132577-200512000-00018
López González ÁA, RiveroLedo YI, Vicente Herrero MT, Gil Llinás M, Tomás Salvá M, Riutord FB (2015) Atherogenic indices in workers of different occupational sectors of the Spanish Mediterranean area. Clin Investig Arterioscler 27(3):118–128. https://doi.org/10.1016/j.arteri.2014.10.004
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. https://doi.org/10.1093/nar/16.3.1215
Article CAS PubMed PubMed Central Google Scholar
De Staercke C, Lally C, Austin H, Winston C, Dowling N, Williams B et al (2007) The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction. Thromb Res 119(1):105–110. https://doi.org/10.1016/j.thromres.2005.12.010
Article CAS PubMed Google Scholar
Shi Y, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2):97–98. https://doi.org/10.1038/sj.cr.7290272
Article CAS PubMed Google Scholar
Santos JL, Lera L, Pérez-Bravo F, Albala C (2006) Adiposity and bone mineral density of Chilean elderly women in relation to toll-like receptor 4 gene polymorphisms. Ann Hum Biol 33(5–6):585–592. https://doi.org/10.1080/03014460601011798
Article CAS PubMed Google Scholar
Jermendy A, Korner A, Kovacs M, Kaszas E, Balázsovics J, Szocs A et al (2010) Association between toll-like receptor polymorphisms and serum levels of tumor necrosis factor-alpha and its soluble receptors in obese children. Med Sci Monit 16(4):180–185
Weyrich P, Staiger H, Stančáková A, Machicao F, Machann J, Schick F et al (2010) The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PLoS ONE 5(11):e13980. https://doi.org/10.1371/journal.pone.0013980
留言 (0)